- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.43 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.2: 5 residues within 4Å:- Chain A: D.61, N.93, Y.94, G.95, D.97
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.61, A:N.93, A:G.95, A:D.97, H2O.8, H2O.8
CA.4: 6 residues within 4Å:- Chain A: D.78, G.79, S.81, L.83, D.101, E.104
6 PLIP interactions:6 interactions with chain A- Metal complexes: A:D.78, A:G.79, A:S.81, A:L.83, A:D.101, A:E.104
CA.9: 5 residues within 4Å:- Chain B: D.61, N.93, Y.94, G.95, D.97
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.61, B:N.93, B:G.95, B:D.97, H2O.17, H2O.18
CA.10: 7 residues within 4Å:- Chain B: D.78, G.79, P.80, S.81, L.83, D.101, E.104
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:D.78, B:G.79, B:S.81, B:L.83, B:D.101, B:E.104
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x AZ4: N-[(2S)-4-(5-fluoropyrimidin-2-yl)-1-({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)butan-2-yl]-N-hydroxyformamide(Non-covalent)
AZ4.6: 22 residues within 4Å:- Chain A: G.82, L.83, L.84, A.85, H.86, A.87, L.117, V.118, H.121, E.122, H.125, H.131, A.137, L.138, F.140, P.141, I.142, Y.143, T.144, F.151
- Chain B: F.6
- Ligands: ZN.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.83, A:H.86
- Hydrogen bonds: A:L.84, A:A.85, A:A.87
- pi-Stacking: A:H.121, A:H.125
AZ4.12: 21 residues within 4Å:- Chain A: F.6
- Chain B: G.82, L.83, L.84, A.85, H.86, A.87, L.117, H.121, E.122, H.125, H.131, A.137, L.138, F.140, P.141, I.142, Y.143, T.144, F.151
- Ligands: ZN.7
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:L.83, B:H.86
- Hydrogen bonds: B:L.84, B:A.85, B:A.87
- pi-Stacking: B:H.121, B:H.125
- Halogen bonds: B:T.144
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Savi, C. et al., Hydantoin based inhibitors of MMP13--discovery of AZD6605. Bioorg.Med.Chem.Lett. (2013)
- Release Date
- 2014-03-05
- Peptides
- Collagenase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.43 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x AZ4: N-[(2S)-4-(5-fluoropyrimidin-2-yl)-1-({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)butan-2-yl]-N-hydroxyformamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Savi, C. et al., Hydantoin based inhibitors of MMP13--discovery of AZD6605. Bioorg.Med.Chem.Lett. (2013)
- Release Date
- 2014-03-05
- Peptides
- Collagenase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B